Loading News...
Back to Dashboard
Humana Inc. logo

Humana Inc. (HUM)

Real-time intraday values

Market Overview

From:
To:
HUM Intraday
No data available
SymbolHUM
IPO DateDec 31, 1981
CEOMr. James A. Rechtin M.B.A.
Full Time Employees67.1k
SectorHealthcare
IndustryHealthcare Plans
CountryUnited States
ExchangeNYSE
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Performance
PeriodReturn %Value Change
1 Day
+8.01%
+30.44 US$
5 Days
+6.36%
+24.54 US$
1 Month
+5.04%
+19.71 US$
6 Months
+142.93%
+241.68 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of HUM...

Key Statistics
Market Cap
49.33B
P/E Ratio
38.86
Div Yield
0.93%
52W High
$428.88
52W Low
$163.11

Analyst Consensus

ConsensusBuy
Bullish1350.0%
Neutral1246.2%
Bearish13.8%

52W Analyst Price Targets

Min Target
$280.00
Max Target
$515.00
Current$410.76
Avg Target$423.74

Analyst Recommendations

Target Price:$423.74($280.00 - $515.00)
FirmRatingTarget PriceUpside PotentialDate
BarclaysOverweight$515.00+25.38%9/25/2026
JP MorganNeutral$393.00-4.32%8/10/2026
Morgan StanleyEqual-Weight$370.00-9.92%8/5/2026
TD CowenHold$370.00-9.92%7/31/2026
BarclaysEqual-Weight$407.00-0.92%7/31/2026
UBSNeutral$405.00-1.40%7/30/2026
Evercore ISI GroupOutperform$480.00+16.86%7/30/2026
GuggenheimBuy$471.00+14.66%7/30/2026
Raymond JamesMarket Perform$0.00-100.00%7/30/2026
TD CowenHold$350.00-14.79%7/14/2026
Community Thoughts

Share your analysis and sentiment on HUM

Join the community to share your analysis